ClinicalTrials.Veeva

Menu

Investigation of a New Diet for the Treatment of Obesity in the NHS

Imperial College London logo

Imperial College London

Status

Completed

Conditions

Obesity

Treatments

Other: I-SatPro weight loss programme
Other: Tier 3 weight loss programme

Study type

Interventional

Funder types

Other

Identifiers

NCT05249439
189449 (Other Identifier)
16/LO/1622 (Other Identifier)
16HH3487

Details and patient eligibility

About

Over one in four adults living in the UK is living with obesity. Obesity is associated with health complications including type 2 diabetes, heart disease and depression. The current NHS treatment for obesity includes attending a specialist hospital weight management service called 'Tier 3' where patients receive help from healthcare professionals such as doctors, dieticians and psychologists. It is known that health conditions associated with obesity improve or reverse if a person with obesity loses five per cent or more of their body weight. On average, currently available Tier 3 programmes achieve less weight loss than this. In our specialist obesity clinic at the Imperial Weight Centre, we (the study research team) have designed a new weight loss programme called Imperial Satiety Protocol (or I-SatPro for short). I-SatPro comprises dietary advice including eating a low carbohydrate (low glycaemic index) diet, eating protein for the satiating effects, eating healthy fats and abstaining from high sugar and/or processed foods which can drive over-eating. Participants will be advised to eat according to subjective feelings of hunger and fullness, rather than eating according to a defined calorie restriction. Similar to other Tier 3 Programmes, I-SatPro also contains locally devised content related to healthy eating, for example fibre intake, the timing of eating, lifestyle change such as exercise, self-care such as advice on sleep and behavioural change strategies.

Full description

The purpose of this feasibility/pilot study is to check whether:

  1. Our patients like I-SatPro
  2. Whether our patients want to follow I-SatPro
  3. Check whether our patients following I-SatPro achieve improvements in their health including: weight loss, changes in blood pressure, changes in diabetes control, changes in blood lipids 'cholesterol', changes in their eating patterns and relationship with food, changes in their wellbeing

Enrollment

21 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged ≥18 years
  • Male or female
  • Body mass index ≥35kg/m2 with at least one obesity related co-morbidity
  • Body mass index ≥40kg/m2 with or without an obesity related co-morbidity
  • Eligible for treatment under the NHS

Exclusion criteria

  • History of any medical, psychological or other condition, or use of any medications, which would either compromise the validity of the study or the safety of the participant
  • English language fluency and comprehension insufficient to be able to participate in educational and group components of the programme
  • Usual residence/place of work is sufficiently far from the study site or logistical/lifestyle factors mean that it is likely that the patient would be unable to attend for all sessions/components of the study
  • Pregnancy or breast feeding
  • Previous bariatric surgery
  • Concurrent participation in another research study which would either compromise the validity of the study or the safety of the participant
  • Previous participation in a study if the investigators judge that this would either compromise the validity of the study or the safety of the participant
  • Unable to give informed consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

21 participants in 2 patient groups

I-SatPro
Experimental group
Description:
Patients in the I-SatPro group will attend I-SatPro patient group weight management sessions (Tier 3 equivalent) and follow the I-SatPro programme
Treatment:
Other: I-SatPro weight loss programme
Control
Active Comparator group
Description:
Patients in the control group will attend the established Imperial Weight Centre Tier 3 patient group weight management sessions and follow the Imperial Weight Centre Tier 3 weight management programme
Treatment:
Other: Tier 3 weight loss programme

Trial documents
1

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems